BioCentury
ARTICLE | Financial News

Amicus Therapeutics financial update

December 17, 2012 8:00 AM UTC

Amicus filed a shelf registration covering the sale of up to $145 million of its securities. The company, which closed Friday at $5.86, has 49.5 million shares outstanding. ...